You can buy or sell Senseonics and other stocks, options, and ETFs commission-free!
Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. Read More The company was founded on June 26, 2014 and is headquartered in Germantown, MD. The listed name for SENS is Senseonics Holdings, Inc.
52 Week High
52 Week Low
— per share
Expected Nov 9, After Hours